Clinical observation of carvedilol treatment in patients with congestive heart failure
Wang Mei-hu
Abstract
Wang Mei-hu
Abstract
Objective To investigate the clinical effects and safety of carvedilol in the treatment of chronic congestive heart failure(CHF).Methods 70 patients with chronic heart failure were randomly divided into conventional group and carvedilol group,Conventional group were given routine treatment such as using nitric acid ester,diuretics,digitalis preparations,ACEI or ARB etc.while carvedilol was added on routine treatment in carvedilol group,period of treatment for six months.Results Compared with conventional group,NYHA class was improved more significantly in carvedilol group(P0.05),and carvedilol group can significantly increased LVEF,reduce LVDd.Conclusion Carvedilol in the treatment of chronic congestive heart failure(NYHA-FC Ⅱ~Ⅲ class) is effective,safe,and shows the role of improving left ventricular remodeling.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the clinical effects and safety of carvedilol in the treatment of chronic congestive heart failure(CHF).Methods 70 patients with chronic heart failure were randomly divided into conventional group and carvedilol group,Conventional group were given routine treatment such as using nitric acid ester,diuretics,digitalis preparations,ACEI or ARB etc.while carvedilol was added on routine treatment in carvedilol group,period of treatment for six months.Results Compared with conventional group,NYHA class was improved more significantly in carvedilol group(P0.05),and carvedilol group can significantly increased LVEF,reduce LVDd.Conclusion Carvedilol in the treatment of chronic congestive heart failure(NYHA-FC Ⅱ~Ⅲ class) is effective,safe,and shows the role of improving left ventricular remodeling.
Key concepts: Carvedilol, Medicine, Heart failure, Digitalis, Cardiology, Internal medicine, Ejection fraction